Eli Lilly and Co., US5324571083

Lam Research stock climbs on a 4.72% premarket gain

Published on 08/13/2026 at 17:31 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Lam Research stock is drawing attention after a 4.72% move and a $408.07 billion market value on August 13, 2026, while the latest quarter showed $6.72 billion in revenue and $1.82 in EPS.

Wissenschaftler im sterilen Pharma-Labor mit Edelstahl-Bioreaktoren und Laborgeräten
Fotorealistisches Pharma-Labor zeigt Eli Lilly and Company mit ISIN US5324571083 in moderner Forschungsumgebung symbolisch, Illustration mit AI erstellt.

Lam Research (US5324571083) stock was up 4.72% to $326.11 in the prior close snapshot and traded at $326.50 in a later premarket update on August 13, 2026, with a market value of $408.07 billion. The move came alongside a sharp semiconductor bid, and the latest reported quarter showed $6.72 billion in revenue and $1.82 in non-GAAP EPS.

Quarterly numbers stay strong

The strongest recent operating figures came from the quarter ended June 30, 2026, when revenue reached $6.72 billion, up 30.0% year over year, and gross margin expanded to 51.7%. Non-GAAP EPS of $1.82 beat the $1.68 estimate by 8.10%, a gap that keeps the latest report in focus for investors.

That combination matters because the stock's current value already reflects a large rerating: MarketBeat's stock page showed a $326.11 close, while the same day's quote snapshot also listed a $408.07 billion market capitalization and a 52-week range of $94.11 to $438.50. A higher starting point leaves less room for simple multiple expansion and puts the next quarter's guidance front and center.

Guidance sets the tone

The most recent outlook points to another heavy quarter, with September quarter revenue guided at $8.10 billion plus or minus $400 million and EPS at $2.15 plus or minus $0.15. On that setup, Lam Research is no longer trading as a pure recovery story; the market is now weighing whether the next print can convert strong wafer-fab equipment demand into another beat.

Semiconductor peers helped the tone as well, with a regional chip rally cited on August 13, 2026 after softer U.S. inflation data and better AI infrastructure earnings. Lam Research's 4.72% rise fits that broader tape, but the company's own $6.72 billion quarterly revenue and 51.7% gross margin still do most of the analytical heavy lifting.

Products still matter

Lam Research's business centers on wafer fabrication equipment used in etch and deposition steps, where its installed base and service revenue can cushion swings in tool demand. That model explains why a quarter with $6.72 billion in sales and a $2.15 EPS guide can move the stock even when the broader semiconductor backdrop is already strong.

Shares and valuation

Lam Research stock was quoted at $326.50 in a delayed premarket update on August 13, 2026, after closing at $326.11 in the prior session. The same quote snapshot put the company at a $408.07 billion market capitalization, which leaves the market focused on execution rather than just momentum.

Company details

Company: Lam Research Corporation

ISIN: US5324571083

Ticker: LRCX

Exchange: Nasdaq

Price (as of August 13, 2026, 8:51 a.m. ET): $326.50 USD

Market cap: $408.07 billion (as of August 13, 2026)

Sector / Industry: Information Technology / Semiconductor Equipment

Index membership: Nasdaq-100

Next earnings date: September 17, 2026

Disclaimer...

en | US5324571083 | ELI LILLY AND CO. | boerse | 69946569 | bgmi